Biotech firm Cellectis Plant Sciences said it secured roughly $20 million in funding, which will go toward adding 10 scientists to its St. Paul staff.
The firm, which uses genetic engineering to produce new crop plants, said it received the money as part of a larger financing round from its parent company, Paris-based Cellectis. The money was from a private investor and a French sovereign fund, said Dan Voytas, chief science officer at Cellectis Plant Sciences, in an e-mail.
The additional staffing will increase Cellectis Plant Sciences to 15 employees, Voytas said. The company is located at the University Enterprise Laboratories in St. Paul.
